4//SEC Filing
GENZYME CORP 4
Accession 0001181431-11-023253
CIK 0000732485operating
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 5:00 PM ET
Size
13.7 KB
Accession
0001181431-11-023253
Insider Transaction Report
Form 4
GENZYME CORPGENZ
GC Merger Corp.
10% Owner
Transactions
- Purchase
Common Stock, $0.01 par value
2011-04-06+3,947,680→ 187,986,225 total(indirect: By GC Merger Corp.) - Purchase
Common Stock, $0.01 par value
2011-04-08$76.33/sh+16,245,894$1,240,049,089→ 253,558,720 total(indirect: By GC Merger Corp.) - Purchase
Common Stock, $0.01 par value
2011-04-08+4,435,393→ 237,312,826 total(indirect: By GC Merger Corp.) - Purchase
Common Stock, $0.01 par value
2011-04-07+44,891,208→ 232,877,433 total(indirect: By GC Merger Corp.)
SANOFI-AVENTIS
10% Owner
Transactions
- Purchase
Common Stock, $0.01 par value
2011-04-06+3,947,680→ 187,986,225 total(indirect: By GC Merger Corp.) - Purchase
Common Stock, $0.01 par value
2011-04-08$76.33/sh+16,245,894$1,240,049,089→ 253,558,720 total(indirect: By GC Merger Corp.) - Purchase
Common Stock, $0.01 par value
2011-04-07+44,891,208→ 232,877,433 total(indirect: By GC Merger Corp.) - Purchase
Common Stock, $0.01 par value
2011-04-08+4,435,393→ 237,312,826 total(indirect: By GC Merger Corp.)
Footnotes (6)
- [F1]Reflects shares purchased in an exchange offer.
- [F2]On April 6, 2011, these shares of Genzyme Corporation ("Genzyme") common stock were exchanged for cash and a contingent value right (each, a "CVR") pursuant to GC Merger Corp.'s ("Purchaser") offer to exchange each issued and outstanding share of Genzyme common stock for $74.00 in cash and one CVR. The closing price of Genzyme common stock on April 5, 2011 was $76.33.
- [F3]The shares are held by Purchaser. The Purchaser is a direct, wholly-owned subsidiary of sanofi-aventis ("Parent"). The shares may also be deemed to be indirectly beneficially owned by Parent.
- [F4]On April 7, 2011, these shares of Genzyme common stock were exchanged for cash and one CVR pursuant to Purchaser's offer to exchange each issued and outstanding share of Genzyme common stock for $74.00 in cash and one CVR. The closing price of Genzyme common stock on April 6, 2011 was 76.38.
- [F5]On April 8, 2011, these shares of Genzyme common stock were exchanged for cash and one CVR pursuant to Purchaser's offer to exchange each issued and outstanding share of Genzyme common stock for $74.00 in cash and one CVR. The closing price of Genzyme common stock on April 7, 2011 was 76.33.
- [F6]Reflects shares acquired by Purchaser pursuant to the exercise of the "top-up" option provided for in the Agreement and Plan of Merger, dated as of February 16, 2011 among Parent, Purchaser and Genzyme.
Documents
Issuer
GENZYME CORP
CIK 0000732485
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0000732485
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 5:00 PM ET
- Size
- 13.7 KB